Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-17-272198
Filing Date
2017-08-30
Accepted
2017-08-29 21:11:36
Documents
11
Period of Report
2017-08-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d445790d6k.htm 6-K 9007
2 EX-99.1 d445790dex991.htm EX-99.1 1284516
3 GRAPHIC g445790dsp12.jpg GRAPHIC 1714
4 GRAPHIC g445790dsp6.jpg GRAPHIC 7599
5 GRAPHIC g445790dsp9.jpg GRAPHIC 1810
6 GRAPHIC g445790g01m12.jpg GRAPHIC 14529
7 GRAPHIC g445790g0829023212051.jpg GRAPHIC 8248
8 GRAPHIC g445790g0829023212324.jpg GRAPHIC 2540
9 GRAPHIC g445790g0829023212573.jpg GRAPHIC 3269
10 GRAPHIC g445790g0829023212894.jpg GRAPHIC 1989
11 GRAPHIC g445790g38f75.jpg GRAPHIC 2439
  Complete submission text file 0001193125-17-272198.txt   1356591
Mailing Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 171059166
SIC: 2834 Pharmaceutical Preparations